IDEAS home Printed from https://ideas.repec.org/a/spr/aphecp/v6y2008i2p103-112.html
   My bibliography  Save this article

Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting

Author

Listed:
  • Elise Pelletier
  • Paula Smith
  • Kristina Boye
  • Derek Misurski
  • Sandra Tunis
  • Michael Minshall

Abstract

These costing results provide an important resource for economic modelling and other types of costing research related to treating diabetes-related complications within the US managed care system. Copyright Adis Data Information BV 2008

Suggested Citation

  • Elise Pelletier & Paula Smith & Kristina Boye & Derek Misurski & Sandra Tunis & Michael Minshall, 2008. "Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting," Applied Health Economics and Health Policy, Springer, vol. 6(2), pages 103-112, July.
    • Handle: RePEc:spr:aphecp:v:6:y:2008:i:2:p:103-112
    DOI: 10.1007/BF03256126
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/BF03256126
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/BF03256126?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Sandra Tunis & Luc Sauriol & Michael Minshall, 2010. "Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada," Applied Health Economics and Health Policy, Springer, vol. 8(4), pages 267-280, July.
    2. Derek Misurski & Maureen Lage & Rosalind Fabunmi & Kristina Boye, 2009. "A comparison of costs among patients with type 2 diabetes mellitus who initiated therapy with exenatide or insulin glargine," Applied Health Economics and Health Policy, Springer, vol. 7(4), pages 245-254, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:aphecp:v:6:y:2008:i:2:p:103-112. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.